Kanuma 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung

7680661600011 CH-66160 Konzentrat
Kanuma 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Kanuma 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Kanuma 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/04/2026
Summary of Product Characteristics
Français
05/04/2026
Summary of Product Characteristics
Italien
05/04/2026
Patient information leaflet
Allemand
20/05/2025
Patient information leaflet
Français
20/05/2025
Patient information leaflet
Italien
20/05/2025

Detailed composition

Substance Quantity Type Category
sebelipasum alfa
2.0 MG Substance Wirkstoff (Principe actif)
trinatrii citras dihydricus
- Substance HNIDK
natrium
3.2 MG Substance HBESI
acidum citricum monohydricum
- Substance HNIDK
albuminum seri humani
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Alexion Pharma GmbH

6340 Baar

Authorization information

Swissmedic authorization number
66160
Drug name
Kanuma, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
A16AB14
Authorization status
Z
Dispensing category
B
First authorization
21/07/2016
Authorization expiration date
31/12/9999
IT Number
04.05.0.
Domain
Human medicine
Field of application
langfristige Enzymersatztherapie bei Patienten aller Altersgruppen mit LAL-Mangel

Package details

Description (FR)
KANUMA 2 mg/ml conc perf 2 mg 1 pce
Description (DE)
KANUMA 2 mg/ml Konz Inf 2 mg 1 Stk
Market launch
21/07/2016
Narcotic (BTM)
No
Buy us a coffee Explore the data